NEWS

NEWS TYPE
RELEASE YEAR

RESEARCH

[Publication]Niche-preserving transplantation promotes functional engraftment of intestinal organoids in rat short bowel syndrome

January 8, 2026

Co-authored by Bio2Q and Keio University researchers, this study demonstrates a niche-preserving transplantation strategy that enables highly efficient engraftment of intestinal organoids in the small intestine. These researchers show that restoring ileal epithelial function within the jejunum improves bile acid absorption and survival in a rat model of short bowel syndrome, highlighting the therapeutic potential of region-targeted regenerative approaches.

Titile Niche-preserving transplantation promotes functional engraftment of intestinal organoids in rat short bowel syndrome
Authors Ryoma Endo [1],[2], Shinya Sugimoto [1],[3], Yutaro Kuwashima [1],[4],[8], Mami Matano [1], Hikaru Hanyu [1], Sirirat Takahashi [1], Hirochika Kato [1],[5], Taku Tanaka [1], Andreas Michael Sihombing [1], Koji Shirosaki [1],[6], Yoshiko Hatano [1], Yuki Sugiura [7],[8], Takanori Kanai [3],[8], Motoshi Wada [2], Toshiro Sato [1], [8],[9]
Short Description This study, co-authored by researchers from both Bio2Q and Keio University, demonstrates how preserving the intestinal stem cell niche can enable functional transplantation of intestinal organoids to treat short bowel syndrome (SBS), a life-threatening condition caused by extensive loss of the small intestine. SBS outcomes depend on ileal function, yet current treatments cannot fully restore the ileum’s absorptive capabilities. Here, researchers developed a niche-preserving epithelial removal method that clears native intestinal stem cells while maintaining the stromal environment. This allowed transplanted ileal organoids to engraft within the jejunum, creating an “ilealized” segment of intestine. In a rat model of SBS, this restored bile acid absorption and improved lipid handling lead to gains in body weight and survival. By directly linking niche preservation to successful stem cell engraftment, this study establishes functional epithelial replacement as a viable therapeutic strategy, and positions organoid transplantation as a promising avenue for treating SBS and other malabsorptive disorders
DOI 10.1016/j.stem.2025.12.007
Journal Cell Stem Cell
Vol/Num/Page 33, 1-9
Publication Date 2025 December 29.

Affiliations:
[1] Department of Integrated Medicine and Biochemistry, Keio University School of Medicine, Tokyo 160-8582, Japan
[2] Department of Pediatric Surgery, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan
[3] Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan
[4] Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo 105-8512, Japan
[5] Department of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan
[6] Department of Pediatric Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan
[7] Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan
[8] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo 160-8582, Japan

More Bio2Q News

ANNOUNCEMENT
2026.11.10

New Member - Dr. Augustinas Silale

Introducing new member of Bio2Q We are excited to welcome Dr.  Augustinas Silale as a Jr. PI at Bio-2 Core of Bio2Q. "Hello, Bio2Q community! My name is Augustinas (August) Silale. I am from Lithuania. I am delighted to join Bio2Q as a Jr. PI. I read Natural Sciences at the University of Cambridge. My BA project was on fragment-based drug discovery in Prof Sir Tom Blundell’s group, where ...

EVENT
2026.11.09

WPI 20th Anniversary Symposium "20 Years of World Premier International Research...

On Sunday, January 24, 2027, the "WPI 20th Anniversary Symposium" will be held at Pacifico Yokohama North with online streaming available, hosted by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS).Marking two decades of the World Premier International Research Center Initiative (WPI), this landmark symposium brings...

ANNOUNCEMENT
2026.11.09

Open Call: Research Administrator (URA)

Bio2Q is seeking a Research Administrator (URA) (Project Instructor or Project Assistant Professor) to promote Bio2Q-related research through their own ideas and initiative. For further details, please refer to the link below. We look forward to receiving your application.   Application Information → https://bio2q.keio.ac.jp/wp-content/uploads/3_URA.pdf

ANNOUNCEMENT
2026.11.06

New Member - Dr. Seongmoon Jo

Introducing new member of Bio2Q We are excited to welcome Dr. Seongmoon Jo as a Postdoctoral Fellow at Bio-2 Core of Bio2Q. "Hello, I am Seongmoon Jo, and I am pleased to join Bio2Q as a postdoctoral researcher in Prof. Nadinath Nillegoda's laboratory. I received my Ph.D. in Medical Science from Yonsei University in South Korea and previously worked as a postdoctoral researcher at Washington...

EVENT
2026.11.04

【11/30 Seminar】WPI-Bio2Q Open Seminar: Saori Sakaue, MD, PhD

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, students, and staff of Keio University. We sincerely look forward to your participation. Date 16:00~17:00, November 30, 2026 Venue 8F Meeting Room Center for Integrated Medical Research Shinanomachi Campus, Keio University Title Decodin...